Cervical Cancer Clinical Trials in Wuhan, Hubei
13 recruitingWuhan, Hubei, China
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 1
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Cervical CancerEndometrial CancerGynecologic Malignancies
Tongji Hospital97 enrolled1 locationNCT06552598
Recruiting
Phase 3
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Cervical Cancer
Lee's Pharmaceutical Limited440 enrolled5 locationsNCT06459687
Recruiting
Phase 2
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
Cervical CancerNeoadjuvant ChemoimmunotherapyLocally Advanced Cervical Cancer+1 more
Tongji Hospital40 enrolled12 locationsNCT06288360
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.200 enrolled24 locationsNCT06799637
Recruiting
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
Cervical Cancer
Zhongnan Hospital10,000 enrolled1 locationNCT06082765
Recruiting
Phase 2Phase 3
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Cervical Cancer
Bio-Thera Solutions526 enrolled1 locationNCT06123884
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Cervical CancerFertility PreservationNeoadjuvant Chemoimmunotherapy
Tongji Hospital40 enrolled2 locationsNCT06289062
Recruiting
Phase 2Phase 3
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Cervical CancerConcurrent ChemoradiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Tongji Hospital440 enrolled12 locationsNCT06288373
Recruiting
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Cervical CancerNeuroendocrine NeoplasmWomen+2 more
Fujian Maternity and Child Health Hospital300 enrolled9 locationsNCT06276309
Recruiting
Phase 2
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Cervical CancerNeoadjuvant ChemoimmunotherapyRadical Hysterectomy+1 more
Tongji Hospital50 enrolled2 locationsNCT06289751
Recruiting
Phase 2
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Cervical Cancer
Zhongnan Hospital35 enrolled1 locationNCT05817214
Recruiting
Phase 3
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
Cervical CancerUterine Cervical Neoplasms
Huazhong University of Science and Technology340 enrolled1 locationNCT04733820